Alan Brooks

Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA.

Cowen & Co. LLC is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 2004 and is a subsidiary of Cowen Holdings, Inc., ultimately owned by The Toronto-Dominion Bank (TSE: TD) in Canada. Cowen & Co. offers industry-focused investment banking for growth-oriented companies, domain knowledge-driven research and a sales and trading platform for institutional investors. Their institutional sales and trading business serves both equity and fixed-income clients. Sales and trading execution platform is structured around the following key verticals: (1) healthcare (2) technology, telecommunications and media (TMT) (3) REITs and financials (4) aerospace and defense (5) consumer and (6) alternative energy.

TargeGen, Inc. manufactures vascular biopharmaceutical products. The company was founded by David A. Cheresh and Peter G. Ulrich in 2001 and is headquartered in San Diego, CA.

MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts.

McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY.

Kleiner Perkins Caufield & Byers LLC (Kleiner Perkins Caufield & Byers) is a venture capital firm founded in 1972 by Eugene Kleiner, Thomas Perkins, Brook Byers and Frank J. Caufield. The firm is headquartered in California, US.

Cameron Health, Inc. develops medical devices for patients and medical professionals. It has developed a totally subcutaneous implantable defibrillator (S-ICD) system that remedies many of the issues associated with traditional implantable cardioverter defibrillators. The company was founded on August 21, 2000 and is headquartered in San Clemente, CA.

Anteis SA modifies and functionalizes injectable hyaluronic acid for medical applications. The firm serves in Asthetic dermatology. The company was founded by Gilles Bos Gilles in March 2003 and is headquartered in Plan-les-Ouates, Switzerland.

swiss smile Holding AG operates as a holding company with interests in operates a chain of dental clinics. It offers treatments in the areas of aesthetic dentistry, bleaching, implantology, orthodontic, oral surgery, endodontic, pediatric dentistry, periodontology, professional teeth cleaning, bad breath, prosthetic, tooth-colored filling, teeth grinding, general anesthetic, and emergency aspects. The firm also provides whitening toothpastes, herbal toothpastes, whitening toothbrushes, soft toothbrushes, waxed dental tapes, and interdental brushes. The company was founded by Haleh Abivardi Brönner and Golnar Abivardi Signer in 2006 and is headquartered in Zurich, Switzerland.

Bellevue Asset Management (Venture Capital) is the venture capital arm of Bellevue Asset Management AG, a subsidiary of Bellevue Group AG (SW: BBN) headquartered in Zurich, Switzerland. The firm was founded in 1993.

Aleva Neurotherapeutics SA develops next-generation implants for deep brain stimulation therapy. Its micro fabricated devices enable target specific stimulation and optimization of current therapies. The company was founded by Claudio Pollo, Jean-Pierre Rosat, Philipe Renaud, Paul Pyzowski and André Mercanzini and in August 2008 and is headquartered in Lausanne, Switzerland.

Informed Data Systems, Inc. is a biotechnology comapny, which engages in the provision of healthcare services. The company was founded by Jeffrey A. Dachis and is headquartered in New York, NY.

eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA.

Triumvira Immunologics, Inc. develops and manufactures pharmaceutical products. The company was founded by Jonathan Bramson in 2015 and is headquartered in Hamilton, Canada.

The Clinical & Translational Science Institute at the University of Pittsburgh is an organization dedicated to advancing medical research and improving patient care. The private company is based in Pittsburgh, PA. The institute's official website provides information about its mission and initiatives.

Bluerock Therapeutics engages in development of a pluripotent stem cell-derived myocardiocytes as regenerative cell therapies for restoring electrical and contractile function in patients with myocardial infarction or chronic heart failure. The company was founded by Gordon Keller and Lorenz Studer in 2016 and is headquartered in Toronto, Canada.

9905553 Canada, Inc. operates as a digital market place that allows buyers and sellers to list, negotiate, and finalize grain deals. The company was founded by Brennan Turner and Alain Goubau and is headquartered in Ontario, Canada.

Peel Therapeutics, Inc. engages as pre-clinical stage biotech that is strategically positioned at the intersection of nature and technology. The company is founded by Joshua Schiffman and Avi Schroeder in 2015 and is headquartered in Salt Lake City, UT.

Ada Health GmbH offers a virtual assessment of health symptoms. It specializes in Personal Health, Artificial Intelligence, mHealth and Health Care services. The company was founded by Martin Hirsch, Daniel Nathrath and Claire Novorol and is headquartered in Berlin, Germany.

Pairwise Plants LLC operates as a agriculture company. The company was founded by Feng Zhang, David Liu and J. Keith Joung and is headquartered in Durham, NC.

Casebia Therapeutics LLP provides physical, chemical, and analytical testing services. The British company was founded in 2016, and Jim Burns has been the CEO of the company since 2019.

Joyn Bio LLC is a joint venture between Leaps by Bayer and Ginkgo Bioworks that engineers microbes to improve naturally occurring processes in agriculture. The company is based in Boston, MA, and has two sites for leading scientists with diverse backgrounds. The company's focus is on developing probiotics for plants to provide growers with next-generation solutions to their biggest challenges. The company's first area of focus is on engineering microbes that provide cereal crops with their nitrogen needs to reduce agriculture's reliance on nitrogen fertilizer and its environmental impact.

Khloris Biosciences, Inc. operates as biotechnology company. The firm offers drug discovery, vaccine and cell therapies for treatment and prevention of cancer. The company was founded by Lynne A. Bui and Joseph C. Wu in June 2017 and is headquartered in Mountain View, CA.

Dewpoint Therapeutics, Inc. develops drugs. The company is headquartered in Boston, MA.

Leaps by Bayer is venture investment unit of Bayer AG (Xetra: BAYN) founded in 2015. The firm is headquartered in Leverkusen, Germany.

Immunitas Therapeutics, Inc. provides cancer therapeutics services. The company was founded by Lea Hachigian, Kai Wucherpfennig, K. Dane Wittrup and Mario Suv? and is headquartered in Cambridge, MA.

Plant Response, Inc. is engaged in providing agricultural biological services. It offers cybelion, power coat, biohp, neptunion, biopath and PRB9 products. The company is headquartered in Durham, NC.

Oerth Bio LLC is an agricultural biotech company that develops sustainable, environmentally-designed crop and farm solutions to reduce the environmental impact of agrochemical solutions and nourish a growing population with eco-friendly, healthy foods. The company is based in Durham, NC. The company was formed as a joint venture between Arvinas and Bayer, supported by over $55 million in committed funding and operational support from Bayer, and technology and intellectual property from Arvinas. Oerth Bio is reimagining crop protection through a comprehensive, therapeutic approach to crop health using Protac® technology, a targeted biotech solution known for its potential in addressing human disease. The CEO of the company is John W. Dombrosky.

Vesigen, Inc. develops groundbreaking therapeutic products directed to intracellular targets using a scalable and extracellular vesicle delivery technology. The company is headquartered in Cambridge, MA.

Angitia Biopharmaceuticals Guangzhou Ltd. develops therapies for musculoskeletal diseases. The company is based in Guangzhou, China. The Chinese company was founded in 2018 by Muyu Li, Hua Zhu Ke. Hua Zhu Ke has been the CEO since 2018.

Affini-T Therapeutics, Inc. is a biotechnology company based in Watertown, MA. Affini-t is focused on developing potentially curative therapies for solid tumor cancers by unlocking the power of T cells and targeting core oncogenic drivers. The company's differentiated cell therapy platform harnesses state-of-the-art engineering and synthetic biology capabilities to optimize T cell functions and rewrite the rules of the solid tumor microenvironment, enabling the potential for sustained clinical outcomes in patients. The company is targeting Kras and other oncogenic and viral driver mutations to open a new and differentiated target space, thereby minimizing the risk of cancer. The company was founded by Jak Knowles and Arjun Goyal, with Jak Knowles serving as the CEO since incorporation.

Triumvira Immunologics USA, Inc. develops and manufactures novel T cell therapies for cancer. The company is based in Austin, TX and has subsidiaries in Canada. Paul Lammers has been the CEO of the company since 2018.